Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Nature Communications|March 7, 2024
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic deliveryZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Biomaterials|February 3, 2024
Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Biomaterials|June 10, 2015
The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecinJianqin Lu, Chuang Liu, Pengcheng Wang, et al.
Nature Nanotechnology|August 13, 2021
Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapyZhiren Wang, Nicholas Little, Jiawei Chen, et al.
The AAPS Journal|September 7, 2014
Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacityYifei Zhang, Yixian Huang, Wenchen Zhao, et al.
The AAPS Journal|November 28, 2013
Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrierPeng Zhang, Jianqin Lu, Yixian Huang, et al.
ACS Nano|November 29, 2018
Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 PathwayJianqin Lu, Xiangsheng Liu, Yu-Pei Liao, et al.
Biomaterials|November 28, 2012
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancersJianqin Lu, Yixian Huang, Wenchen Zhao, et al.
Bioconjugate Chemistry|June 12, 2012
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxelYixian Huang, Jianqin Lu, Xiang Gao, et al.
Nature Communications|November 9, 2023
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Pageof 6